EGFR and non-small cell lung carcinoma: To verify whether icotinib inhibits proliferation of NSCLC cells, HCC827 cells (harboring an EGFR mutation E746-A750del) and A549 cells (EGFR wild type) were exposed to 1 nM to 100 μM icotinib for 48 and 72 h.